市場調查報告書
商品編碼
1273559
到 2028 年的神經血管導管市場預測——按類型(血栓切除術導管、微導管、球囊導管、栓塞導管、通路導管、其他類型)、按應用、按最終用戶、按地區分類的全球分析Neurovascular Catheters Market Forecasts to 2028 - Global Analysis By Type (Thrombectomy Catheters, Microcatheters, Balloon Catheters, Embolization Catheters, Access Catheters and Other Types), Application, End User and By Geography |
根據 Stratistics MRC 的數據,2022 年全球神經血管導管市場規模將達到 33 億美元,預計到 2028 年將達到 58 億美元,預測期內增長 9.8%。預計將以復合年增長率增長。
神經血管導管還可用於將神經血管裝置輸送到大腦等神經血管器官。 因此,神經血管導管被用於許多顱腦手術。 由於神經手術的大量增加,神經血管導管的使用逐漸增加。 此外,在治療缺血性中風方面也取得了許多進展,例如正在幫助導管行業的再通道支架和支架回收器。
美國疾病控制與預防中心估計,美國每年約有 795,000 人中風。
神經血管導管與其他神經血管裝置一起用於治療中風。 因此,神經血管導管已在各種顱內手術中得到應用。 神經外科手術數量顯著增加,神經血管導管的消耗量逐漸增加。 此外,採用符合人體工程學設計和提高臨床效率的先進導管的推出正在推動市場的增長。
儘管中風和出血的頻率越來越高,並且患有神經血管疾病的患者越來越多,但仍有一些限制阻礙了神經血管導管的廣泛採用。 這是由於神經血管導管的高成本和不利的報銷政策。 因此,在這些國家接受治療的患者和使用導管的人數減少。
從開放手術到微創手術的轉變對於開髮用於許多應用的先進神經血管導管至關重要。 中風發病率的上升、神經系統疾病的流行以及醫療保健專業人員對微創手術的偏好增加了發達國家和發展中國家對這些導管的需求。
與使用導管相關的程序問題給市場帶來了一些挑戰。 限制市場對神經血管導管需求的主要因素之一是導管阻塞的風險、導管脫落以及與神經血管器官的生物相容性。 此外,嚴格的監管也阻礙了市場的擴張。
隨著受影響人數的增加,對醫療用品的需求也越來越大。 霧化器、生命支持設備、制氧機和監護儀等呼吸支持設備是一線臨床實踐中使用的醫療設備的典型示例。 此外,COVID-19 顯著增加了對口罩、手套和防護眼鏡等醫療用品的需求。 由於世界上越來越多的病例,不僅醫療專業人員而且普通消費者對醫療用品的需求也在不斷增加。
由於急性缺血性中風的患病率上升,估計微導管部分的增長利潤豐厚。 在神經血管治療中,它是一個放入血管中的小空心管。 這些先進的導管具有多種特性,包括親水塗層、柔軟性、可跟蹤性和穩定性。 該細分市場的擴張預計將受到主要市場進入者在不久的將來使用的增長技術的增加,例如產品發布。
由於手術時間的減少和微創手術技術的進步,門診手術中心部分預計在預測期內將以最快的複合年增長率增長。 與醫院相比,我們可以為患者提供很多好處,比如縮短手術時間,當天出院。 它也比醫院便宜,因此患者可以節省很多錢。 這些因素促成了其快速增長。
由於疾病覆蓋範圍擴大、技術進步和神經系統疾病患病率增加等因素,亞太地區預計在預測期內將佔據最大的市場份額。 該地區缺血、腦動脈瘤和動靜脈畸形等神經血管疾病發病率的增加是導致這一上升的原因之一。 此外,該地區的增長是由該地區重要參與者的存在和不斷增加的醫療保健成本推動的。
由於對神經血管疾病的認識不斷提高、對微創手術的關注度不斷提高以及先進導管的廣泛採用,預計歐洲在預測期內的複合年增長率最高。 此外,政府活動的增加和公司研發支出的增加極大地推動了該地區的市場擴張。
2021 年 9 月,Medtronic PLC 獲得了 Rist 079 徑向通路指南和 Rist 徑向通路選擇性導管的 CE 批准。 它旨在解決通過橈動脈進行神經血管通路的需求。
2021 年 6 月,Penumbra 將以優化的可跟蹤性推出,以導航大腦復雜的遠端血管解剖結構,並提供強大的抽吸以清除血塊。我們設計的 RED 62 導管已獲得美國 FDA 批准。
訂閱此報告的客戶將獲得以下免費定制選項之一。
According to Stratistics MRC, the Global Neurovascular Catheters Market is accounted for $3.3 billion in 2022 and is expected to reach $5.8 billion by 2028 growing at a CAGR of 9.8% during the forecast period. Neurovascular catheters are also useful for delivering neurovascular devices to neurovascular organs, such as the brain. The use of neurovascular catheters in numerous cranial surgeries is a result. The use of neurovascular catheters has gradually increased as a result of a considerable increase in neurological procedures. Additionally, there have been a number of advancements in the treatment of ischemic stroke, including flow-rerouting stents and stent retrievers that are assisting in the catheter industry.
According to the estimations of Centers for Disease Control and Prevention, around 795,000 people in the U.S. suffer from a stroke each year.
Along with other neurovascular devices, neurovascular catheters are utilised in the treatment of strokes. Consequently, neurovascular catheters are applied in various cranial procedures. There has been a significant rise in the number of neurological procedures gradually increasing the consumption of neurovascular catheters. Also, introduction of advanced catheters with ergonomic designs and improved clinical efficiency is fueling the market growth.
Despite an increase in the frequency of strokes and haemorrhages as well as a sizable patient population suffering from neurovascular illnesses, there are some limitations that are preventing the widespread use of neurovascular catheters. This is brought on by the procedures' high cost and the unfavourable reimbursement policies. As a result, there are fewer patients receiving therapy and fewer catheters are being used in these nations.
The transition from open surgery to minimally invasive surgery has been crucial in the development of sophisticated neurovascular catheters for many uses. The demand for these catheters is rising in both developed and developing nations due to the rising incidence of stroke and the prevalence of neurological illnesses as well as the preference of healthcare providers for less invasive surgeries.
The procedural concerns connected to the use of these catheters provide certain difficulties for the market. One of the main factors restricting the demand for neurovascular catheters in the market is the risk of catheter blockage, coating removal from the catheter, and its biocompatibility with neurovascular organs. Furthermore, strict rules are also preventing the market from expanding.
Medical supplies are increasingly in demand as a result of the afflicted population. Among the most common medical devices used in first-line clinical care are respiratory support devices such atomizers, life support machines, oxygen generators, and monitors. Additionally, COVID-19 has caused a significant increase in demand for medical goods such masks, gloves, and protective eyewear. The demand for medical goods is continuously increasing from both healthcare professionals and the general public as a result of an increase in instances around the world.
The microcatheters segment is estimated to have a lucrative growth, due to the rising prevalence of acute ischemic stroke. For neurovascular treatments, they are tiny, hollow tubes that are placed into blood vessels. These advanced catheters are made with a variety of features, including a hydrophilic coating, softness, trackability, and stability. The segment's expansion will be fueled in the near future by an increase in the number of growth methods used by major market participants, such as product launches.
The ambulatory surgical centers segment is anticipated to witness the fastest CAGR growth during the forecast period, due to shorter procedure time and advancements in minimally invasive surgical techniques. In comparison to hospitals, they provide patients with a number of benefits, including as faster operation times and same-day discharge. Patients can save a lot of money by using them because they can be less expensive than hospitals. These factors have contributed to its rapid growth.
Asia Pacific is projected to hold the largest market share during the forecast period owing to the factors such as rising target disease burden, technological advancements, increasing prevalence of neurological disorders. The increasing incidence of neurovascular illnesses in this region, such as ischemia, brain aneurysms, and arteriovenous malformations, is one reason contributing to this rise. Additionally, the region's growth is being aided by the presence of important players in the area and growing healthcare costs.
Europe is projected to have the highest CAGR over the forecast period, owing to the rising awareness about the neurovascular disorders, the increasing focus on minimally invasive surgeries, and high adoption of advanced catheters. The expansion of the regional market is also being considerably aided by greater government activities as well as increasing R&D spending by businesses.
Some of the key players profiled in the Neurovascular Catheters Market include: Integra Holdings Corporation, Stryker, Concentric Medical, Inc., Medtronic, Johnson and Johnson company, Zeus Industrial Products, Acandis GmbH, Terumo Corporation, Penumbra, Inc., Biomerics, Creganna Medical, Microvention Inc. and DePuy Synthes.
In September 2021, Medtronic PLC received CE approval for Rist 079 Radial Access Guide and Rist Radial Access Selective Catheter. It aims to cater the needs of accessing neuro vasculature through the radial artery.
In June 2021, Penumbra received US FDA Clearance for its RED 62 catheters, designed with optimized trackability to help navigate the complex distal vessel anatomy in the brain and deliver powerful aspiration for the removal of blood clots.
All the customers of this report will be entitled to receive one of the following free customization options: